Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
0.48
-0.02 (-3.81%)
At close: May 01, 2025, 3:59 PM
0.51
4.40%
Pre-market: May 02, 2025, 04:24 AM EDT
Lineage Cell Therapeutics Revenue
Lineage Cell Therapeutics reported an annual revenue of $9.5M, reflecting a undefined% growth. For the quarter ending December 31, 2024, Lineage Cell Therapeutics generated $2.87M in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
110.5M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 9.5M | +6.19% |
| Dec 31, 2023 | 8.95M | -39.16% |
| Dec 31, 2022 | 14.7M | +277.39% |
| Dec 31, 2021 | 3.9M | +404.01% |
| Dec 31, 2020 | 773K | n/a |